Lenalidomide for mild cognitive impairment
Treatments studied
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study tests whether the drug lenalidomide can help people with mild cognitive impairment, a condition that affects memory and thinking. It aims to see if the drug can slow down or improve thinking problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 89 years old.
- You have been diagnosed with mild cognitive impairment affecting memory.
- You have a study partner (like a family member or friend) who spends at least 10 hours a week with you and can help with visits and medication.
- You are willing to have a lumbar puncture (spinal tap) and PET and MRI brain scans.
- You live in the community (not in a nursing home or assisted living).
- You have had a brain scan showing amyloid plaques, which are linked to Alzheimer's disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a medicine called siponimod, already used for multiple sclerosis, can help people with mild Alzheimer's dementia. You will take a pill daily and be monitored closely for safety and cognitive changes.
This study tests a low dose of radiation to the whole brain combined with an experimental drug to see if it can slow down the effects of mild Alzheimer's disease. It aims to help people with mild dementia think more clearly and keep their daily abilities for as long as possible.
This study tests a new medicine, NVP-NK4146, for people with mild cognitive impairment (MCI) due to Alzheimer's disease. The goal is to see if it can help slow down memory and thinking problems.
This trial is testing an experimental medicine called QLH2405 in two groups: healthy volunteers (to check safety) and people with mild memory problems due to Alzheimer's. If you qualify, the study may help find out if this new treatment is safe and could slow down memory decline.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This study looks at how well lecanemab works for people with early Alzheimer's disease. It aims to see if the drug can help slow down memory and thinking problems.
Hear when a new Cognitive Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.